Veterinary Medicines

Avishield ND +IB H120

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
  • Newcastle disease virus, strain La Sota, Live
Download as PDF

Product identification

Medicine name:
Avishield ND +IB H120
AVISHIELD ND + IB H120 liofilizat za okulonazalno suspenzijo/dajanje v vodo za pitje za piščance
Active substance:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
  • Newcastle disease virus, strain La Sota, Live
Target species:
  • Chicken
Route of administration:
  • Oculonasal use
  • In drinking water use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
    3.50
    log 10 50% embryo infective dose/dose
    /
    1.00
    Vial
  • Newcastle disease virus, strain La Sota, Live
    6.00
    log10 tissue culture infective dose 50/dose
    /
    1.00
    Vial
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken
      • Meat and offal
        0
        day
  • In drinking water use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:
  • The vaccine is filled into colourless glass vials (type I), which are closed with rubber stoppers (brombutyl) and sealed with aluminium caps. 10x2500 dose
  • The vaccine is filled into colourless glass vials (type I), which are closed with rubber stoppers (brombutyl) and sealed with aluminium caps. 10x1000 dose

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Genera d.d.
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • DC/V/0628/001
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0130/001
Concerned member states:
  • Croatia
  • Slovenia

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 4/03/2024
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 4/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."